GO:1904659 D-glucose transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904659 (D-glucose transmembrane transport) is the biological process by which D-glucose is moved across a membrane, a fundamental step in cellular energy supply and metabolic regulation.
• Facilitative glucose transporters (GLUT/SLC2A family) and sodium-coupled glucose transporters (SGLT/SLC5A family) are the principal protein mediators of this process in mammals.
• D-glucose transmembrane transport is essential for insulin secretion by pancreatic beta cells, as glucose uptake and metabolism trigger the secretory cascade.
• Altered expression or function of glucose transporters is linked to cancer metabolism, diabetes, and drug pharmacokinetics.
• Yeast hexose transporters (HXT) provide a powerful model for studying the molecular genetics of hexose transport and for engineering sugar specificity.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of glucose transporter genes in health and disease.
Description
D-glucose transmembrane transport (GO:1904659) is defined as the process in which D-glucose is transported across a membrane. This biological process is central to cellular metabolism because glucose is a primary energy substrate and a precursor for many biosynthetic pathways. In mammals, glucose cannot freely diffuse across lipid bilayers; instead, it requires specialized membrane proteins that facilitate its movement down or against concentration gradients. The molecular players include facilitative diffusion carriers such as GLUT1 (SLC2A1) and sodium-dependent cotransporters such as SGLT1 (SLC5A1), which couple glucose uptake to ion gradients. In yeast, hexose transporters of the HXT family mediate glucose uptake and have been extensively characterized genetically. Understanding GO:1904659 is therefore essential for researchers in metabolism, endocrinology, oncology, and drug delivery, as it underpins processes ranging from insulin secretion to tumor growth and chemotherapeutic targeting.
D-glucose transmembrane transport At A Glance
| GO ID | GO:1904659 |
|---|---|
| GO term | D-glucose transmembrane transport |
| Ontology | biological_process |
| Synonym | glucose transmembrane transport; glucose transport |
| Definition | The process in which D-glucose is transported across a membrane. |
| Major function | Mediates the movement of D-glucose across cellular membranes, enabling energy uptake and metabolic regulation. |
| Key transporters | GLUT/SLC2A family (facilitative), SGLT/SLC5A family (sodium-coupled), yeast HXT family. |
| Physiological relevance | Essential for insulin secretion, tissue glucose homeostasis, and drug transport. |
| Disease links | Cancer (glioblastoma), diabetes, and altered drug pharmacokinetics. |
What Is GO:1904659?
GO:1904659 describes the directed movement of the monosaccharide D-glucose across a biological membrane. This process can occur via facilitated diffusion, secondary active transport, or other transport mechanisms, and it is distinct from glucose metabolism or signaling. The term encompasses transport across the plasma membrane as well as intracellular membranes, and it is mediated by specific transporter proteins that recognize D-glucose with high selectivity.
Why Is D-glucose transmembrane transport Important in Cell Biology?
D-glucose transmembrane transport is a prerequisite for glucose utilization by cells and thus lies at the heart of energy metabolism. It controls the rate of glucose entry into cells, influences insulin secretion in pancreatic beta cells, and supports the high metabolic demands of cancer cells. Moreover, because many drugs are conjugated to glucose to exploit these transporters, understanding this process has direct implications for drug design and delivery.
• Provides the primary route for glucose uptake in most mammalian cells, sustaining ATP production and biosynthetic pathways.
• Regulates insulin secretion in pancreatic beta cells, linking glucose transport to endocrine control of blood sugar.
• Supports the metabolic reprogramming of cancer cells, including glioblastoma, where GLUT1 is often overexpressed.
• Influences drug pharmacokinetics through glucose-conjugated prodrugs that hijack glucose transporters.
• Serves as a target for engineering sugar specificity in yeast, with applications in biofuel and industrial biotechnology.
• Underpins the molecular genetics of hexose transport, as elucidated in yeast models.
• Contributes to whole-body glucose homeostasis and is implicated in diabetes and metabolic disorders.
• Enables synthetic chemists to design artificial channels for selective glucose transport, inspiring new biomimetic systems.
• Provides a paradigm for studying membrane protein structure-function relationships and transport mechanisms.
• Offers opportunities for therapeutic intervention in cancer and metabolic diseases by targeting specific transporters.
What Happens During D-glucose transmembrane transport?
Glucose recognition and binding
In simple terms: The transporter protein grabs a glucose molecule from one side of the membrane.
Transport begins when a D-glucose molecule binds to a specific site on a transporter protein embedded in the membrane. Facilitative transporters such as GLUT1 (SLC2A1) recognize D-glucose with stereospecificity, while sodium-coupled transporters like SGLT1 (SLC5A1) bind glucose together with sodium ions. In yeast, hexose transporters (HXT) similarly bind D-glucose and related hexoses, though with varying affinities.
Conformational change and translocation
In simple terms: The transporter changes shape to move the glucose across the membrane.
Upon binding, the transporter undergoes conformational changes that expose the glucose molecule to the opposite side of the membrane. For facilitative diffusion, this process is driven by the glucose concentration gradient and does not require ATP. For sodium-coupled transport, the energy stored in the sodium gradient drives glucose uptake against its own concentration gradient. The molecular details of these conformational cycles have been studied in both mammalian and yeast systems.
Release of glucose into the cytoplasm
In simple terms: The glucose is let go inside the cell.
After translocation, the transporter releases D-glucose into the cytoplasm or into the lumen of an organelle, depending on the membrane and transporter type. This release completes the transport cycle and allows the transporter to reset for another round. In pancreatic beta cells, the subsequent metabolism of glucose leads to insulin secretion, linking transport to endocrine function.
Regulation by cellular signals
In simple terms: Cells can adjust how much glucose they take up based on their needs.
The activity and abundance of glucose transporters are regulated by hormones, nutrients, and stress signals. For example, insulin promotes the translocation of GLUT4 to the plasma membrane in muscle and fat cells, enhancing glucose uptake. In cancer cells, oncogenic signaling can upregulate GLUT1 expression and its palmitoylation, which promotes glycolysis and tumorigenesis. Such regulatory layers ensure that D-glucose transmembrane transport matches cellular metabolic demand.
Key Genes Involved in GO:1904659 D-glucose transmembrane transport
The following genes encode proteins that directly mediate or regulate D-glucose transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Facilitative glucose transporter; mediates basal glucose uptake in many tissues. | Overexpressed in cancers; target for metabolic studies and drug delivery. |
| SLC2A2 (GLUT2) | Facilitative transporter with high capacity; important in liver, pancreas, and kidney. | Linked to glucose sensing and insulin secretion. |
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter in muscle and adipose tissue. | Key player in whole-body glucose homeostasis and diabetes research. |
| SLC5A1 (SGLT1) | Sodium-coupled glucose transporter in intestine and kidney. | Target for diabetes drugs and studies of active transport. |
| SLC5A2 (SGLT2) | Sodium-coupled glucose transporter in kidney; mediates renal glucose reabsorption. | Therapeutic target for SGLT2 inhibitors in diabetes. |
| HXT1 | Yeast hexose transporter with low affinity; expressed at high glucose. | Model for studying hexose transport genetics. |
| HXT2 | Yeast hexose transporter with high affinity; expressed at low glucose. | Used in engineering sugar specificity. |
| HXT4 | Yeast hexose transporter involved in glucose uptake. | Studied for transport kinetics and regulation. |
| HXT5 | Yeast hexose transporter with moderate affinity. | Model for stress-induced transport. |
| HXT6 | Yeast high-affinity glucose transporter. | Used in metabolic engineering. |
| HXT7 | Yeast high-affinity glucose transporter. | Target for improving xylose utilization. |
| GAL2 | Yeast galactose transporter that also transports glucose. | Model for substrate specificity studies. |
| SNF3 | Yeast glucose sensor; not a transporter but regulates HXT expression. | Component of glucose signaling pathways. |
| RGT2 | Yeast glucose sensor; regulates HXT gene expression. | Studied in glucose sensing and signaling. |
| DHHC9 | Palmitoyltransferase that modifies GLUT1. | Regulates GLUT1 localization and function in cancer. |
| TP53 | Tumor suppressor that can influence glucose metabolism indirectly. | Context-dependent effects on glucose transport. |
| HIF1A | Transcription factor that upregulates GLUT1 under hypoxia. | Links oxygen sensing to glucose uptake in tumors. |
| INS | Insulin; regulates GLUT4 translocation and glucose uptake. | Central to endocrine control of glucose homeostasis. |
How Is D-glucose transmembrane transport Regulated?
D-glucose transmembrane transport is regulated at multiple levels. Hormonal signals such as insulin promote the translocation of GLUT4-containing vesicles to the plasma membrane, increasing glucose uptake in muscle and fat. In pancreatic beta cells, glucose entry and metabolism are coupled to insulin secretion, forming a feedback loop that maintains blood glucose levels. At the molecular level, post-translational modifications such as S-palmitoylation of GLUT1 by DHHC9 enhance its membrane retention and function, promoting glycolysis and tumorigenesis. Transcriptional regulation by hypoxia-inducible factors (e.g., HIF1A) upregulates GLUT1 under low oxygen, supporting anaerobic metabolism in cancer. In yeast, glucose sensing pathways involving SNF3 and RGT2 adjust the expression of HXT transporters according to extracellular glucose availability.
D-glucose transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 (GLUT1) | Glioblastoma, cancer metabolism | Knockout or overexpression in glioblastoma cell lines; point mutations to disrupt palmitoylation site. |
| SLC2A4 (GLUT4) | Type 2 diabetes, insulin resistance | Knockout in muscle cells; knock-in of tagged GLUT4 for trafficking studies. |
| SLC5A2 (SGLT2) | Diabetes, renal glucose reabsorption | Knockout in kidney epithelial cells; point mutations to study inhibitor binding. |
| HXT7 | Yeast sugar utilization, biofuel production | Overexpression or point mutations to alter substrate specificity. |
| SLC5A1 (SGLT1) | Glucose-galactose malabsorption | Knockout in intestinal cell models; knock-in of patient mutations. |
Cancer metabolism and glioblastoma
Many cancer cells exhibit increased glucose uptake to support rapid proliferation, a phenomenon known as the Warburg effect. In glioblastoma, DHHC9-mediated S-palmitoylation of GLUT1 promotes its localization to the plasma membrane, enhancing glycolysis and tumorigenesis. Targeting glucose transporters or their regulatory enzymes is therefore a potential therapeutic strategy.
Diabetes and metabolic disorders
Defects in glucose transport contribute to insulin resistance and hyperglycemia. GLUT4 dysfunction in muscle and adipose tissue impairs postprandial glucose disposal, while SGLT2 in the kidney regulates glucose reabsorption. Insulin secretion by pancreatic beta cells depends on glucose uptake and metabolism, linking transport to type 2 diabetes.
Drug transport and pharmacokinetics
Glucose transporters can mediate the cellular uptake of glucose-conjugated drugs, influencing their bioavailability and tissue targeting. For example, a sugar-linked isophosphoramide mustard derivative exploits transmembrane glucose transport for drug delivery. Understanding these interactions is crucial for designing better therapeutics.
From D-glucose transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GLUT1 affect tumor growth? | CRISPR knockout of SLC2A1 in glioblastoma cell lines. |
| How does palmitoylation regulate GLUT1 localization? | Point mutation of the palmitoylation site in SLC2A1. |
| Can a tagged GLUT4 be used to track insulin-induced translocation? | Knock-in of fluorescent protein tag at the endogenous SLC2A4 locus. |
| Does overexpression of HXT7 improve xylose fermentation? | Overexpression of HXT7 in engineered yeast strains. |
| What is the effect of SGLT2 inhibitor on glucose uptake? | Knockout of SLC5A2 in kidney cells and treatment with inhibitors. |
| Can artificial channels selectively transport glucose? | Synthetic porphyrin boxes as biomimetic models. |
How to Study the D-glucose transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Determine necessity of a transporter for glucose uptake. |
| Point mutation | Effect of specific amino acid changes | Study palmitoylation site or substrate binding residues. |
| Knock-in tagging | Protein localization and dynamics | Track GLUT4 trafficking in live cells. |
| Overexpression | Gain of function | Enhance glucose transport in engineered yeast. |
| Glucose uptake assay | Rate of glucose transport | Compare wild-type and mutant cells. |
| RNA-seq | Transcriptional changes | Identify transporters upregulated in cancer. |
| Proteomics | Protein abundance and modifications | Detect palmitoylation of GLUT1. |
| Synthetic chemistry | Design of artificial channels | Mimic glucose transport with porphyrin boxes. |
Genetic knockout and knockdown
CRISPR-Cas9 knockout or RNA interference can be used to eliminate specific glucose transporter genes, allowing researchers to assess their contribution to glucose uptake and downstream phenotypes. For example, knockout of SLC2A1 in cancer cells reduces glucose consumption and tumor growth.
Transport assays
Radiolabeled or fluorescent glucose analogs (e.g., 2-NBDG) are commonly used to measure transport activity in live cells. These assays can be combined with genetic perturbations to determine the kinetic properties of specific transporters.
Protein localization and trafficking
Fluorescence microscopy and subcellular fractionation can track the localization of tagged transporters, such as GLUT4, in response to insulin or other stimuli. Knock-in of epitope tags facilitates these studies.
Omics and bioinformatics
Transcriptomics and proteomics can reveal expression changes in glucose transporter genes across conditions. Bioinformatics analyses of public datasets help identify co-regulated genes and pathways, as seen in studies of yeast hexose transporters.
How CRISPR Can Be Used to Study GO:1904659 D-glucose transmembrane transport
Knockout
CRISPR knockout of glucose transporter genes (e.g., SLC2A1, SLC2A4) creates cell models to study the consequences of losing specific transport activities. These models are valuable for validating drug targets and understanding metabolic dependencies in cancer and diabetes.
Point Mutation
Introducing precise point mutations in transporter genes allows researchers to dissect the roles of specific residues in substrate binding, transport kinetics, and post-translational modifications. For example, mutating the palmitoylation site of GLUT1 can reveal its impact on membrane localization and tumorigenesis.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes at endogenous loci enables real-time tracking of transporter expression and trafficking. This approach is particularly useful for studying insulin-responsive GLUT4 translocation.
Overexpression
CRISPR activation or cDNA overexpression can increase the abundance of specific glucose transporters, enhancing glucose uptake. This is used in metabolic engineering of yeast to improve sugar utilization.
How EDITGENE Supports D-glucose transmembrane transport Research
Researchers studying D-glucose transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in glucose uptake, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for D-glucose transmembrane transport research.
Frequently Asked Questions About D-glucose transmembrane transport
What is D-glucose transmembrane transport?
D-glucose transmembrane transport (GO:1904659) is the biological process by which the sugar D-glucose is moved across a cell membrane, typically mediated by specific transporter proteins.
What genes are involved in D-glucose transmembrane transport?
Key genes include SLC2A1 (GLUT1), SLC2A4 (GLUT4), SLC5A1 (SGLT1), SLC5A2 (SGLT2), and yeast HXT genes.
How is D-glucose transported across the membrane?
It is transported by facilitative diffusion (e.g., GLUTs) or secondary active transport (e.g., SGLTs), depending on the transporter and cell type.
What is the role of GLUT1 in glucose transport?
GLUT1 (SLC2A1) mediates basal glucose uptake in many tissues and is often overexpressed in cancer cells to support glycolysis.
How does insulin affect glucose transport?
Insulin stimulates the translocation of GLUT4 to the plasma membrane in muscle and fat cells, increasing glucose uptake.
What diseases are linked to defects in glucose transport?
Defects are associated with diabetes, cancer metabolism, and glucose-galactose malabsorption.
Can CRISPR be used to study glucose transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect transporter function.
What methods measure glucose transport activity?
Common methods include radiolabeled or fluorescent glucose uptake assays, such as 2-NBDG, and genetic screens.
How is glucose transport regulated in cells?
It is regulated by hormones (e.g., insulin), nutrients, and post-translational modifications like palmitoylation.
What is the difference between GLUT and SGLT transporters?
GLUTs facilitate diffusion down the concentration gradient, while SGLTs couple glucose transport to sodium ion movement.
Conclusion
D-glucose transmembrane transport (GO:1904659) is a fundamental biological process that governs cellular glucose uptake and metabolism. Its dysregulation is implicated in cancer, diabetes, and drug response, making it a critical area of research. By leveraging CRISPR-based models and advanced bioinformatics, researchers can uncover new insights into the molecular mechanisms and therapeutic potential of glucose transporters.
References
- 1. Zhang Z et al.. 2021. DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis.. Nat Commun 12(1):5872 PMID: 34620861
- 2. Lee HG et al.. 2023. Synthetic Monosaccharide Channels: Size-Selective Transmembrane Transport of Glucose and Fructose Mediated by Porphyrin Boxes.. Angew Chem Int Ed Engl 62(2):e202214326 PMID: 36382990
- 3. Täljedal IB. 1981. On insulin secretion.. Diabetologia 21(1):1-17 PMID: 7024025
- 4. Oka Y. 1996. [Glucose transporter].. Nihon Rinsho 54(3):632-7 PMID: 8904216
- 5. Farwick A et al.. 2014. Engineering of yeast hexose transporters to transport D-xylose without inhibition by D-glucose.. Proc Natl Acad Sci U S A 111(14):5159-64 PMID: 24706835
- 6. Wang X et al.. 2020. Role of Glucose Transporters in Drug Membrane Transport.. Curr Drug Metab 21(12):947-958 PMID: 32778021
- 7. Boles E et al.. 1997. The molecular genetics of hexose transport in yeasts.. FEMS Microbiol Rev 21(1):85-111 PMID: 9299703
- 8. Pohl J et al.. 1995. D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport.. Cancer Chemother Pharmacol 35(5):364-70 PMID: 7850916
